Current Status of HIV/AIDS in Cameroon: How Effective are Control Strategies?
Open Access
- 31 December 2008
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 5 (5), 378-383
- https://doi.org/10.3390/ijerph5050378
Abstract
Nearly three decades after its discovery, HIV infection remains the number one killer disease in Sub-Saharan Africa where up to 67% of the world’s 33 million infected people live. In Cameroon, based on a Demographic Health Survey carried out in 2004, the national HIV prevalence is estimated at 5.5% with women and youths being predominantly infected. Orphans and vulnerable children (OVC) from the HIV and AIDS pandemic have increased steadily over the years; hospital occupancy is estimated at about 30%, hence stretching the health system; co-infections like HIV/tuberculosis have been reported to reach 40-50% of infected cases and 95% of teachers are said not to be productive on several counts. Thus, the impact is multi-sectorial. Furthermore, the HIV epidemic in Cameroon is peculiar because of the wide HIV-1 genetic diversity of HIV-1 Group M observed with several subtypes reported (A, B, C, D, F, G, H, J, K), predominantly subtype A. There are also circulating recombinant forms, mainly CRF02_AG. In addition, HIV-1 Groups O and N have all been noted in Cameroon. These findings have great implications not only for HIV diagnosis, but also for responsiveness to therapy as well as for vaccine development. In 1986, the initial response of the Cameroon government to the increasing trends in the HIV/AIDS infection was to create a National AIDS Control Committee to coordinate a national AIDS programme. By 2000, the first National Strategic Plan was drawn for 2000-2005. The second National Strategic Plan for 2006-2010 is currently being implemented and covers various axes. Some results obtained show that there has been significantly positive outcomes noted in the various arms of intervention by the Cameroon government.Keywords
This publication has 17 references indexed in Scilit:
- Molecular Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 in Yaoundé, Cameroon: Evidence of Major Drug Resistance Mutations in Newly Diagnosed Patients Infected with Subtypes Other than Subtype BJournal of Clinical Microbiology, 2008
- Emergence of Antiretroviral Therapy Resistance-Associated Primary Mutations Among Drug-Naive HIV-1-Infected Individuals in Rural Western CameroonJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- HIV Genetic Diversity in Cameroon: Possible Public Health ImportanceAIDS Research and Human Retroviruses, 2006
- Prevention of Mother-to-Child Transmission of HIV in Cameroon: Experiences from the University Teaching Hospital in Yaounde (Cameroon)Zentralblatt Fur Gynakologie, 2006
- Identification of a Highly Divergent HIV Type 2 and Proposal for a Change in HIV Type 2 ClassificationAIDS Research and Human Retroviruses, 2004
- Human Immunodeficiency Virus Type 1 Group M Protease in Cameroon: Genetic Diversity and Protease Inhibitor Mutational FeaturesJournal of Clinical Microbiology, 2002
- Identification of a new human immunodeficiency virus type 1 distinct from group M and group ONature Medicine, 1998
- Trends of AIDS Epidemic in Cameroon, 1986 Through 1995JAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemicJAMA, 1993
- Antigenic evidence of the presence of the aberrant HIV-1ANT70 virus in Cameroon and GabonAIDS, 1993